Corentec Co

Corentec Co Debt/EBITDA

The Total Debt to EBITDA Ratio of Corentec Co (104540.KQ) as of Oct 15, 2026 is 0.48. In the previous year, Total Debt to EBITDA Ratio was 3.62 — a change of -86.60% (lower).

Debt/EBITDA

0.48

YoY

-86.60%

Last updated:

Total Debt to EBITDA Ratio of Corentec Co is 2025 0.48 . Total Debt to EBITDA Ratio of Corentec Co was 2024 3.62 . It decreases by -86.60% lower compared to the previous year.

The Corentec Co Debt/EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt/EBITDA
Date
Debt/EBITDA
Jan 1, 2018
-1.00 KRW
Jan 1, 2019
2.71 KRW
Jan 1, 2020
6.33 KRW
Jan 1, 2021
7.91 KRW
Jan 1, 2022
3.15 KRW
Jan 1, 2023
1.21 KRW
Jan 1, 2024
3.62 KRW
Jan 1, 2025
0.48 KRW
The Corentec Co Debt/EBITDA history
YEARDebt/EBITDAYoY
0.48-86.60%
3.62+199.80%
1.21-61.63%
3.15-60.21%
7.91+24.86%
6.33+133.88%
2.71-370.05%
-1.00-82.46%
-5.72-200.75%
5.67+200.62%
1.89-78.74%
8.88—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Corentec Co Stock analysis

What does Corentec Co do? Corentec Co Ltd is a South Korean company headquartered in Cheonan, operating within the Health Care sector. The company went public on March 5, 2013, as indicated by its IPO date. Corentec specializes in the manufacture and sale of artificial articulations, focusing on orthopedic products. Its product portfolio includes hip systems such as primary systems, hemi-arthroplasty systems, and revision systems, featuring cementless and cemented femoral stems, acetabular cups, and bearing systems. The company also offers knee products, comprising primary fixed and mobile type systems, revision knee systems, and augment systems. Additionally, Corentec provides spine products, including pedicle screws and peek cages. The firm markets its hip products under the BENCOX brand, while knee and spine products are sold under the LOSPA and LOSPA IS brand names, respectively. Corentec serves both domestic and international markets, distributing its products globally. The company's website is www.corentec.com. Corentec's business model centers on developing and commercializing orthopedic solutions for joint replacement and spinal care, with a focus on quality and innovation in medical devices. The company's operations are based in Cheonan, South Korea, and it has maintained a presence in the health care industry since its IPO in 2013. Corentec Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Corentec Co stock

Total Debt to EBITDA Ratio of Corentec Co is 0.48 in 2025.

Total Debt to EBITDA Ratio of Corentec Co changed from 3.62 to 0.48, representing a -86.60% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Total Debt to EBITDA Ratio Corentec Co since 2006 – with annual values, charts, and detailed analysis.

Debt/EBITDA measures total debt relative to earnings before interest, taxes, depreciation, and amortization. It indicates the years needed to repay all debt from EBITDA.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Total Debt to EBITDA Ratio's Corentec Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Corentec Co

All Key Metrics — Corentec Co